William Blair Predicts Celsius' Q3 Earnings (NASDAQ:CELH)

Key Points

• William Blair analysts have revised Celsius Holdings' Q3 2025 earnings per share estimate to $0.24, increasing from a previous forecast of $0.20.
• Celsius reported Q2 earnings of $0.47 per share, significantly surpassing the consensus estimate of $0.23, and achieved a substantial net revenue of $739.30 million, up 83.9% year-over-year.
• A majority of investment analysts rate Celsius stock as a "Moderate Buy", with an average target price of $62.40 based on recent assessments from multiple research firms.

Celsius Holdings Inc. (NASDAQ:CELH - Free Report) - Analysts at William Blair boosted their Q3 2025 EPS estimates for shares of Celsius in a research report issued on Monday, October 6th. William Blair analyst J. Andersen now expects that the company will post earnings of $0.24 per share for the quarter, up from their prior forecast of $0.20. The consensus estimate for Celsius' current full-year earnings is $0.89 per share. William Blair also issued estimates for Celsius' FY2025 earnings at $1.08 EPS and FY2026 earnings at $1.44 EPS.

Celsius (NASDAQ:CELH - Get Free Report) last issued its quarterly earnings data on Thursday, August 7th. The company reported $0.47 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.23 by $0.24. Celsius had a net margin of 7.91% and a return on equity of 36.88%. The company had revenue of $739.30 million for the quarter, compared to the consensus estimate of $632.13 million. During the same period last year, the firm posted $0.28 EPS. Celsius's revenue for the quarter was up 83.9% on a year-over-year basis.

A number of other research firms have also recently weighed in on CELH. The Goldman Sachs Group started coverage on Celsius in a research report on Thursday, September 11th. They set a "buy" rating and a $72.00 price objective for the company. Mizuho increased their price target on Celsius from $85.00 to $90.00 and gave the stock an "outperform" rating in a report on Tuesday, September 2nd. UBS Group boosted their price objective on shares of Celsius from $64.00 to $73.00 and gave the company a "buy" rating in a research note on Tuesday, September 2nd. TD Cowen upgraded shares of Celsius from a "hold" rating to a "buy" rating and upped their price objective for the stock from $37.00 to $55.00 in a research report on Monday, June 16th. Finally, Weiss Ratings reaffirmed a "hold (c)" rating on shares of Celsius in a report on Saturday, September 27th. Nineteen investment analysts have rated the stock with a Buy rating, three have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $62.40.

Celsius Stock Performance

NASDAQ CELH opened at $59.11 on Tuesday. The company has a quick ratio of 1.76, a current ratio of 2.11 and a debt-to-equity ratio of 0.68. Celsius has a 52-week low of $21.10 and a 52-week high of $63.50. The business's 50-day moving average price is $55.59 and its 200 day moving average price is $45.28. The firm has a market cap of $15.25 billion, a P/E ratio of 159.76, a P/E/G ratio of 1.32 and a beta of 1.38.

Insiders Place Their Bets

In other Celsius news, insider Paul H. Storey sold 7,500 shares of the firm's stock in a transaction dated Wednesday, September 3rd. The shares were sold at an average price of $60.93, for a total transaction of $456,975.00. Following the completion of the transaction, the insider directly owned 37,550 shares in the company, valued at approximately $2,287,921.50. This trade represents a 16.65% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CFO Jarrod Langhans sold 5,000 shares of the company's stock in a transaction dated Monday, August 18th. The shares were sold at an average price of $60.00, for a total transaction of $300,000.00. Following the completion of the sale, the chief financial officer directly owned 104,227 shares in the company, valued at $6,253,620. This trade represents a 4.58% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 560,667 shares of company stock valued at $27,240,162. Company insiders own 2.55% of the company's stock.

Institutional Investors Weigh In On Celsius

A number of institutional investors and hedge funds have recently bought and sold shares of the stock. Alliancebernstein L.P. increased its position in Celsius by 3.4% during the second quarter. Alliancebernstein L.P. now owns 18,662,921 shares of the company's stock worth $865,773,000 after buying an additional 617,743 shares in the last quarter. Ameriprise Financial Inc. boosted its stake in shares of Celsius by 20.9% during the second quarter. Ameriprise Financial Inc. now owns 2,470,088 shares of the company's stock valued at $114,587,000 after acquiring an additional 426,623 shares during the last quarter. Invesco Ltd. increased its position in Celsius by 1.8% during the 1st quarter. Invesco Ltd. now owns 2,394,811 shares of the company's stock worth $85,303,000 after purchasing an additional 42,997 shares in the last quarter. Holocene Advisors LP raised its stake in Celsius by 130.6% in the 2nd quarter. Holocene Advisors LP now owns 2,108,041 shares of the company's stock valued at $97,792,000 after purchasing an additional 1,193,707 shares during the last quarter. Finally, MIG Capital LLC lifted its holdings in Celsius by 42.7% in the 1st quarter. MIG Capital LLC now owns 1,575,939 shares of the company's stock valued at $56,135,000 after purchasing an additional 471,287 shares in the last quarter. Hedge funds and other institutional investors own 60.95% of the company's stock.

Celsius Company Profile

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.